Pelthos Therapeutics (PTHS) Operating Expenses (2023 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Operating Expenses of $21.4 million for Q4 2025, up 231.09% year-over-year from $6.5 million in Q4 2024, and down 6.04% quarter-over-quarter from $22.8 million in Q3 2025.
Pelthos Therapeutics (PTHS) Operating Expenses (2023 - 2026) Analysis & Trends
Pelthos Therapeutics' Operating Expenses history runs 3 years deep, the most recent figure standing at $21.4 million for Q4 2025.
- In Q4 2025, Operating Expenses rose 231.09% year-over-year to $21.4 million; the TTM figure through Dec 2025 stood at $49.2 million (up 364.55% YoY), while the FY2025 annual figure was $49.2 million, up 550.18% from the prior year.
- Operating Expenses for Q4 2025 stood at $21.4 million, down from $22.8 million in the prior quarter.
- The five-year high for Operating Expenses was $22.8 million in Q3 2025, with the low at $437000.0 in Q3 2024.
- The 3-year median for Operating Expenses is $1.9 million (2024), against an average of $5.6 million.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses sank 66.17% in 2024, then jumped 5110.07% in 2025.
- Pelthos Therapeutics' Operating Expenses stood at $3.9 million in 2023, then jumped by 66.57% to $6.5 million in 2024, then surged by 231.09% to $21.4 million in 2025.
- Business Quant data shows PTHS's Operating Expenses at $21.4 million in Q4 2025, $22.8 million in Q3 2025, and $3.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Pelthos Therapeutics | 94.50 Mn | 69.94 Mn | 21.23 Mn | 56.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.92 Mn |
| Dec 31, 2025 | 21.39 Mn |
| Sep 30, 2025 | 22.77 Mn |
| Jun 30, 2025 | 3.23 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Dec 31, 2024 | 6.46 Mn |
| Sep 30, 2024 | 437,000.00 |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 3.88 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 777,160.00 |
| Mar 31, 2023 | 914,583.00 |